The global β-Lactam Antibiotics market was valued at US$ 27220 million in 2023 and is anticipated to reach US$ 37790 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

β-Lactam Antibiotics Market

β-lactam antibiotics refer to a large class of antibiotics with a β-lactam ring in their chemical structure. These antibiotics have the advantages of strong bactericidal activity, low toxicity, wide indications and good clinical efficacy.

Antibiotics are a class of secondary metabolites produced by microorganisms (including bacteria, fungi, actinomycetes) or higher animals and plants in the course of life, which have anti-pathogen or other activities, and can interfere with the development and function of other living cells. . There are many kinds of antibiotics, which are mainly divided into two categories: ß-lactams and non-ß-lactams. Among them, ß-lactams have the most varieties and are the most widely used in clinical practice. From the perspective of medication structure, β-lactam antibiotics accounted for 55% of the anti-infective drugs in China. With the gradual recovery of the global economy, the continuous growth of the total population and the improvement of the aging society, the scale of the global pharmaceutical market has maintained a steady growth. From the perspective of the terminal market, the current global market size of antibiotic preparations is about 50 billion US dollars. Antibiotic products and markets are relatively mature, but due to the rigid demand for antibiotics in clinical treatment, the industry still shows a low growth trend.

This report aims to provide a comprehensive presentation of the global market for β-Lactam Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding β-Lactam Antibiotics.

Report Scope

The β-Lactam Antibiotics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global β-Lactam Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the β-Lactam Antibiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of β-Lactam Antibiotics Market Report

Report Metric	Details
Report Name	β-Lactam Antibiotics Market
Accounted market size in 2023	US$ 27220 million
Forecasted market size in 2030	US$ 37790 million
CAGR	4.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Penicillin Oxycephems Carbapenems Cephalosporins Others
Segment by Application	Hospital Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	ACS Dobfar, CSPC, United Laboratories, Novartis, LKPC, Changsheng Pharma, North China Pharmaceuticals, Centrient Pharmaceutical, Aurobindo Pharma, Yili Chuanning Biotechnology, Jiangxi Fushine Pharmaceutical, QILU Pharmaceutical, Jiangxi Huabang Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of β-Lactam Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of β-Lactam Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is β-Lactam Antibiotics Market growing?

Ans: The β-Lactam Antibiotics Market witnessing a CAGR of 4.8% during the forecast period 2024-2030.

What is the β-Lactam Antibiotics Market size in 2030?

Ans: The β-Lactam Antibiotics Market size in 2030 will be US$ 37790 million.

What is the β-Lactam Antibiotics Market share by region?

Ans: From the perspective of medication structure, β-lactam antibiotics accounted for 55% of the anti-infective drugs in China.

Who are the main players in the β-Lactam Antibiotics Market report?

Ans: The main players in the β-Lactam Antibiotics Market are ACS Dobfar, CSPC, United Laboratories, Novartis, LKPC, Changsheng Pharma, North China Pharmaceuticals, Centrient Pharmaceutical, Aurobindo Pharma, Yili Chuanning Biotechnology, Jiangxi Fushine Pharmaceutical, QILU Pharmaceutical, Jiangxi Huabang Pharmaceutical

What are the Application segmentation covered in the β-Lactam Antibiotics Market report?

Ans: The Applications covered in the β-Lactam Antibiotics Market report are Hospital, Clinic

What are the Type segmentation covered in the β-Lactam Antibiotics Market report?

Ans: The Types covered in the β-Lactam Antibiotics Market report are Penicillin, Oxycephems, Carbapenems, Cephalosporins, Others

1 β-Lactam Antibiotics Market Overview

1.1 Product Overview and Scope of β-Lactam Antibiotics

1.2 β-Lactam Antibiotics Segment by Type

1.2.1 Global β-Lactam Antibiotics Market Value Comparison by Type (2024-2030)

1.2.2 Penicillin

1.2.3 Oxycephems

1.2.4 Carbapenems

1.2.5 Cephalosporins

1.2.6 Others

1.3 β-Lactam Antibiotics Segment by Application

1.3.1 Global β-Lactam Antibiotics Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.4 Global β-Lactam Antibiotics Market Size Estimates and Forecasts

1.4.1 Global β-Lactam Antibiotics Revenue 2019-2030

1.4.2 Global β-Lactam Antibiotics Sales 2019-2030

1.4.3 Global β-Lactam Antibiotics Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 β-Lactam Antibiotics Market Competition by Manufacturers

2.1 Global β-Lactam Antibiotics Sales Market Share by Manufacturers (2019-2024)

2.2 Global β-Lactam Antibiotics Revenue Market Share by Manufacturers (2019-2024)

2.3 Global β-Lactam Antibiotics Average Price by Manufacturers (2019-2024)

2.4 Global β-Lactam Antibiotics Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of β-Lactam Antibiotics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of β-Lactam Antibiotics, Product Type & Application

2.7 β-Lactam Antibiotics Market Competitive Situation and Trends

2.7.1 β-Lactam Antibiotics Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest β-Lactam Antibiotics Players Market Share by Revenue

2.7.3 Global β-Lactam Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 β-Lactam Antibiotics Retrospective Market Scenario by Region

3.1 Global β-Lactam Antibiotics Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global β-Lactam Antibiotics Global β-Lactam Antibiotics Sales by Region: 2019-2030

3.2.1 Global β-Lactam Antibiotics Sales by Region: 2019-2024

3.2.2 Global β-Lactam Antibiotics Sales by Region: 2025-2030

3.3 Global β-Lactam Antibiotics Global β-Lactam Antibiotics Revenue by Region: 2019-2030

3.3.1 Global β-Lactam Antibiotics Revenue by Region: 2019-2024

3.3.2 Global β-Lactam Antibiotics Revenue by Region: 2025-2030

3.4 North America β-Lactam Antibiotics Market Facts & Figures by Country

3.4.1 North America β-Lactam Antibiotics Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America β-Lactam Antibiotics Sales by Country (2019-2030)

3.4.3 North America β-Lactam Antibiotics Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe β-Lactam Antibiotics Market Facts & Figures by Country

3.5.1 Europe β-Lactam Antibiotics Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe β-Lactam Antibiotics Sales by Country (2019-2030)

3.5.3 Europe β-Lactam Antibiotics Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific β-Lactam Antibiotics Market Facts & Figures by Country

3.6.1 Asia Pacific β-Lactam Antibiotics Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific β-Lactam Antibiotics Sales by Country (2019-2030)

3.6.3 Asia Pacific β-Lactam Antibiotics Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America β-Lactam Antibiotics Market Facts & Figures by Country

3.7.1 Latin America β-Lactam Antibiotics Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America β-Lactam Antibiotics Sales by Country (2019-2030)

3.7.3 Latin America β-Lactam Antibiotics Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa β-Lactam Antibiotics Market Facts & Figures by Country

3.8.1 Middle East and Africa β-Lactam Antibiotics Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa β-Lactam Antibiotics Sales by Country (2019-2030)

3.8.3 Middle East and Africa β-Lactam Antibiotics Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global β-Lactam Antibiotics Sales by Type (2019-2030)

4.1.1 Global β-Lactam Antibiotics Sales by Type (2019-2024)

4.1.2 Global β-Lactam Antibiotics Sales by Type (2025-2030)

4.1.3 Global β-Lactam Antibiotics Sales Market Share by Type (2019-2030)

4.2 Global β-Lactam Antibiotics Revenue by Type (2019-2030)

4.2.1 Global β-Lactam Antibiotics Revenue by Type (2019-2024)

4.2.2 Global β-Lactam Antibiotics Revenue by Type (2025-2030)

4.2.3 Global β-Lactam Antibiotics Revenue Market Share by Type (2019-2030)

4.3 Global β-Lactam Antibiotics Price by Type (2019-2030)

5 Segment by Application

5.1 Global β-Lactam Antibiotics Sales by Application (2019-2030)

5.1.1 Global β-Lactam Antibiotics Sales by Application (2019-2024)

5.1.2 Global β-Lactam Antibiotics Sales by Application (2025-2030)

5.1.3 Global β-Lactam Antibiotics Sales Market Share by Application (2019-2030)

5.2 Global β-Lactam Antibiotics Revenue by Application (2019-2030)

5.2.1 Global β-Lactam Antibiotics Revenue by Application (2019-2024)

5.2.2 Global β-Lactam Antibiotics Revenue by Application (2025-2030)

5.2.3 Global β-Lactam Antibiotics Revenue Market Share by Application (2019-2030)

5.3 Global β-Lactam Antibiotics Price by Application (2019-2030)

6 Key Companies Profiled

6.1 ACS Dobfar

6.1.1 ACS Dobfar Corporation Information

6.1.2 ACS Dobfar Description and Business Overview

6.1.3 ACS Dobfar β-Lactam Antibiotics Sales, Revenue and Gross Margin (2019-2024)

6.1.4 ACS Dobfar β-Lactam Antibiotics Product Portfolio

6.1.5 ACS Dobfar Recent Developments/Updates

6.2 CSPC

6.2.1 CSPC Corporation Information

6.2.2 CSPC Description and Business Overview

6.2.3 CSPC β-Lactam Antibiotics Sales, Revenue and Gross Margin (2019-2024)

6.2.4 CSPC β-Lactam Antibiotics Product Portfolio

6.2.5 CSPC Recent Developments/Updates

6.3 United Laboratories

6.3.1 United Laboratories Corporation Information

6.3.2 United Laboratories Description and Business Overview

6.3.3 United Laboratories β-Lactam Antibiotics Sales, Revenue and Gross Margin (2019-2024)

6.3.4 United Laboratories β-Lactam Antibiotics Product Portfolio

6.3.5 United Laboratories Recent Developments/Updates

6.4 Novartis

6.4.1 Novartis Corporation Information

6.4.2 Novartis Description and Business Overview

6.4.3 Novartis β-Lactam Antibiotics Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novartis β-Lactam Antibiotics Product Portfolio

6.4.5 Novartis Recent Developments/Updates

6.5 LKPC

6.5.1 LKPC Corporation Information

6.5.2 LKPC Description and Business Overview

6.5.3 LKPC β-Lactam Antibiotics Sales, Revenue and Gross Margin (2019-2024)

6.5.4 LKPC β-Lactam Antibiotics Product Portfolio

6.5.5 LKPC Recent Developments/Updates

6.6 Changsheng Pharma

6.6.1 Changsheng Pharma Corporation Information

6.6.2 Changsheng Pharma Description and Business Overview

6.6.3 Changsheng Pharma β-Lactam Antibiotics Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Changsheng Pharma β-Lactam Antibiotics Product Portfolio

6.6.5 Changsheng Pharma Recent Developments/Updates

6.7 North China Pharmaceuticals

6.6.1 North China Pharmaceuticals Corporation Information

6.6.2 North China Pharmaceuticals Description and Business Overview

6.6.3 North China Pharmaceuticals β-Lactam Antibiotics Sales, Revenue and Gross Margin (2019-2024)

6.4.4 North China Pharmaceuticals β-Lactam Antibiotics Product Portfolio

6.7.5 North China Pharmaceuticals Recent Developments/Updates

6.8 Centrient Pharmaceutical

6.8.1 Centrient Pharmaceutical Corporation Information

6.8.2 Centrient Pharmaceutical Description and Business Overview

6.8.3 Centrient Pharmaceutical β-Lactam Antibiotics Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Centrient Pharmaceutical β-Lactam Antibiotics Product Portfolio

6.8.5 Centrient Pharmaceutical Recent Developments/Updates

6.9 Aurobindo Pharma

6.9.1 Aurobindo Pharma Corporation Information

6.9.2 Aurobindo Pharma Description and Business Overview

6.9.3 Aurobindo Pharma β-Lactam Antibiotics Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Aurobindo Pharma β-Lactam Antibiotics Product Portfolio

6.9.5 Aurobindo Pharma Recent Developments/Updates

6.10 Yili Chuanning Biotechnology

6.10.1 Yili Chuanning Biotechnology Corporation Information

6.10.2 Yili Chuanning Biotechnology Description and Business Overview

6.10.3 Yili Chuanning Biotechnology β-Lactam Antibiotics Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Yili Chuanning Biotechnology β-Lactam Antibiotics Product Portfolio

6.10.5 Yili Chuanning Biotechnology Recent Developments/Updates

6.11 Jiangxi Fushine Pharmaceutical

6.11.1 Jiangxi Fushine Pharmaceutical Corporation Information

6.11.2 Jiangxi Fushine Pharmaceutical β-Lactam Antibiotics Description and Business Overview

6.11.3 Jiangxi Fushine Pharmaceutical β-Lactam Antibiotics Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Jiangxi Fushine Pharmaceutical β-Lactam Antibiotics Product Portfolio

6.11.5 Jiangxi Fushine Pharmaceutical Recent Developments/Updates

6.12 QILU Pharmaceutical

6.12.1 QILU Pharmaceutical Corporation Information

6.12.2 QILU Pharmaceutical β-Lactam Antibiotics Description and Business Overview

6.12.3 QILU Pharmaceutical β-Lactam Antibiotics Sales, Revenue and Gross Margin (2019-2024)

6.12.4 QILU Pharmaceutical β-Lactam Antibiotics Product Portfolio

6.12.5 QILU Pharmaceutical Recent Developments/Updates

6.13 Jiangxi Huabang Pharmaceutical

6.13.1 Jiangxi Huabang Pharmaceutical Corporation Information

6.13.2 Jiangxi Huabang Pharmaceutical β-Lactam Antibiotics Description and Business Overview

6.13.3 Jiangxi Huabang Pharmaceutical β-Lactam Antibiotics Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Jiangxi Huabang Pharmaceutical β-Lactam Antibiotics Product Portfolio

6.13.5 Jiangxi Huabang Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 β-Lactam Antibiotics Industry Chain Analysis

7.2 β-Lactam Antibiotics Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 β-Lactam Antibiotics Production Mode & Process

7.4 β-Lactam Antibiotics Sales and Marketing

7.4.1 β-Lactam Antibiotics Sales Channels

7.4.2 β-Lactam Antibiotics Distributors

7.5 β-Lactam Antibiotics Customers

8 β-Lactam Antibiotics Market Dynamics

8.1 β-Lactam Antibiotics Industry Trends

8.2 β-Lactam Antibiotics Market Drivers

8.3 β-Lactam Antibiotics Market Challenges

8.4 β-Lactam Antibiotics Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Yili Chuanning Biotechnology

Jiangxi Fushine Pharmaceutical

Qilu Pharmaceutical

Jiangxi Huabang Pharmaceutical

North China Pharmaceuticals

Centrient Pharmaceutical

ACS Dobfar

List of Tables

Table 1. Global β-Lactam Antibiotics Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global β-Lactam Antibiotics Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global β-Lactam Antibiotics Market Competitive Situation by Manufacturers in 2023

Table 4. Global β-Lactam Antibiotics Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global β-Lactam Antibiotics Sales Market Share by Manufacturers (2019-2024)

Table 6. Global β-Lactam Antibiotics Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global β-Lactam Antibiotics Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market β-Lactam Antibiotics Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of β-Lactam Antibiotics, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of β-Lactam Antibiotics, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of β-Lactam Antibiotics, Product Type & Application

Table 12. Global Key Manufacturers of β-Lactam Antibiotics, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global β-Lactam Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in β-Lactam Antibiotics as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global β-Lactam Antibiotics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global β-Lactam Antibiotics Sales by Region (2019-2024) & (K Units)

Table 18. Global β-Lactam Antibiotics Sales Market Share by Region (2019-2024)

Table 19. Global β-Lactam Antibiotics Sales by Region (2025-2030) & (K Units)

Table 20. Global β-Lactam Antibiotics Sales Market Share by Region (2025-2030)

Table 21. Global β-Lactam Antibiotics Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global β-Lactam Antibiotics Revenue Market Share by Region (2019-2024)

Table 23. Global β-Lactam Antibiotics Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global β-Lactam Antibiotics Revenue Market Share by Region (2025-2030)

Table 25. North America β-Lactam Antibiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America β-Lactam Antibiotics Sales by Country (2019-2024) & (K Units)

Table 27. North America β-Lactam Antibiotics Sales by Country (2025-2030) & (K Units)

Table 28. North America β-Lactam Antibiotics Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America β-Lactam Antibiotics Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe β-Lactam Antibiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe β-Lactam Antibiotics Sales by Country (2019-2024) & (K Units)

Table 32. Europe β-Lactam Antibiotics Sales by Country (2025-2030) & (K Units)

Table 33. Europe β-Lactam Antibiotics Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe β-Lactam Antibiotics Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific β-Lactam Antibiotics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific β-Lactam Antibiotics Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific β-Lactam Antibiotics Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific β-Lactam Antibiotics Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific β-Lactam Antibiotics Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America β-Lactam Antibiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America β-Lactam Antibiotics Sales by Country (2019-2024) & (K Units)

Table 42. Latin America β-Lactam Antibiotics Sales by Country (2025-2030) & (K Units)

Table 43. Latin America β-Lactam Antibiotics Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America β-Lactam Antibiotics Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa β-Lactam Antibiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa β-Lactam Antibiotics Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa β-Lactam Antibiotics Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa β-Lactam Antibiotics Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa β-Lactam Antibiotics Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global β-Lactam Antibiotics Sales (K Units) by Type (2019-2024)

Table 51. Global β-Lactam Antibiotics Sales (K Units) by Type (2025-2030)

Table 52. Global β-Lactam Antibiotics Sales Market Share by Type (2019-2024)

Table 53. Global β-Lactam Antibiotics Sales Market Share by Type (2025-2030)

Table 54. Global β-Lactam Antibiotics Revenue (US$ Million) by Type (2019-2024)

Table 55. Global β-Lactam Antibiotics Revenue (US$ Million) by Type (2025-2030)

Table 56. Global β-Lactam Antibiotics Revenue Market Share by Type (2019-2024)

Table 57. Global β-Lactam Antibiotics Revenue Market Share by Type (2025-2030)

Table 58. Global β-Lactam Antibiotics Price (US$/Unit) by Type (2019-2024)

Table 59. Global β-Lactam Antibiotics Price (US$/Unit) by Type (2025-2030)

Table 60. Global β-Lactam Antibiotics Sales (K Units) by Application (2019-2024)

Table 61. Global β-Lactam Antibiotics Sales (K Units) by Application (2025-2030)

Table 62. Global β-Lactam Antibiotics Sales Market Share by Application (2019-2024)

Table 63. Global β-Lactam Antibiotics Sales Market Share by Application (2025-2030)

Table 64. Global β-Lactam Antibiotics Revenue (US$ Million) by Application (2019-2024)

Table 65. Global β-Lactam Antibiotics Revenue (US$ Million) by Application (2025-2030)

Table 66. Global β-Lactam Antibiotics Revenue Market Share by Application (2019-2024)

Table 67. Global β-Lactam Antibiotics Revenue Market Share by Application (2025-2030)

Table 68. Global β-Lactam Antibiotics Price (US$/Unit) by Application (2019-2024)

Table 69. Global β-Lactam Antibiotics Price (US$/Unit) by Application (2025-2030)

Table 70. ACS Dobfar Corporation Information

Table 71. ACS Dobfar Description and Business Overview

Table 72. ACS Dobfar β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. ACS Dobfar β-Lactam Antibiotics Product

Table 74. ACS Dobfar Recent Developments/Updates

Table 75. CSPC Corporation Information

Table 76. CSPC Description and Business Overview

Table 77. CSPC β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. CSPC β-Lactam Antibiotics Product

Table 79. CSPC Recent Developments/Updates

Table 80. United Laboratories Corporation Information

Table 81. United Laboratories Description and Business Overview

Table 82. United Laboratories β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. United Laboratories β-Lactam Antibiotics Product

Table 84. United Laboratories Recent Developments/Updates

Table 85. Novartis Corporation Information

Table 86. Novartis Description and Business Overview

Table 87. Novartis β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Novartis β-Lactam Antibiotics Product

Table 89. Novartis Recent Developments/Updates

Table 90. LKPC Corporation Information

Table 91. LKPC Description and Business Overview

Table 92. LKPC β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. LKPC β-Lactam Antibiotics Product

Table 94. LKPC Recent Developments/Updates

Table 95. Changsheng Pharma Corporation Information

Table 96. Changsheng Pharma Description and Business Overview

Table 97. Changsheng Pharma β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Changsheng Pharma β-Lactam Antibiotics Product

Table 99. Changsheng Pharma Recent Developments/Updates

Table 100. North China Pharmaceuticals Corporation Information

Table 101. North China Pharmaceuticals Description and Business Overview

Table 102. North China Pharmaceuticals β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. North China Pharmaceuticals β-Lactam Antibiotics Product

Table 104. North China Pharmaceuticals Recent Developments/Updates

Table 105. Centrient Pharmaceutical Corporation Information

Table 106. Centrient Pharmaceutical Description and Business Overview

Table 107. Centrient Pharmaceutical β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Centrient Pharmaceutical β-Lactam Antibiotics Product

Table 109. Centrient Pharmaceutical Recent Developments/Updates

Table 110. Aurobindo Pharma Corporation Information

Table 111. Aurobindo Pharma Description and Business Overview

Table 112. Aurobindo Pharma β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Aurobindo Pharma β-Lactam Antibiotics Product

Table 114. Aurobindo Pharma Recent Developments/Updates

Table 115. Yili Chuanning Biotechnology Corporation Information

Table 116. Yili Chuanning Biotechnology Description and Business Overview

Table 117. Yili Chuanning Biotechnology β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Yili Chuanning Biotechnology β-Lactam Antibiotics Product

Table 119. Yili Chuanning Biotechnology Recent Developments/Updates

Table 120. Jiangxi Fushine Pharmaceutical Corporation Information

Table 121. Jiangxi Fushine Pharmaceutical Description and Business Overview

Table 122. Jiangxi Fushine Pharmaceutical β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Jiangxi Fushine Pharmaceutical β-Lactam Antibiotics Product

Table 124. Jiangxi Fushine Pharmaceutical Recent Developments/Updates

Table 125. QILU Pharmaceutical Corporation Information

Table 126. QILU Pharmaceutical Description and Business Overview

Table 127. QILU Pharmaceutical β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. QILU Pharmaceutical β-Lactam Antibiotics Product

Table 129. QILU Pharmaceutical Recent Developments/Updates

Table 130. Jiangxi Huabang Pharmaceutical Corporation Information

Table 131. Jiangxi Huabang Pharmaceutical Description and Business Overview

Table 132. Jiangxi Huabang Pharmaceutical β-Lactam Antibiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Jiangxi Huabang Pharmaceutical β-Lactam Antibiotics Product

Table 134. Jiangxi Huabang Pharmaceutical Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. β-Lactam Antibiotics Distributors List

Table 138. β-Lactam Antibiotics Customers List

Table 139. β-Lactam Antibiotics Market Trends

Table 140. β-Lactam Antibiotics Market Drivers

Table 141. β-Lactam Antibiotics Market Challenges

Table 142. β-Lactam Antibiotics Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of β-Lactam Antibiotics

Figure 2. Global β-Lactam Antibiotics Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global β-Lactam Antibiotics Market Share by Type in 2023 & 2030

Figure 4. Penicillin Product Picture

Figure 5. Oxycephems Product Picture

Figure 6. Carbapenems Product Picture

Figure 7. Cephalosporins Product Picture

Figure 8. Others Product Picture

Figure 9. Global β-Lactam Antibiotics Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global β-Lactam Antibiotics Market Share by Application in 2023 & 2030

Figure 11. Hospital

Figure 12. Clinic

Figure 13. Global β-Lactam Antibiotics Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global β-Lactam Antibiotics Market Size (2019-2030) & (US$ Million)

Figure 15. Global β-Lactam Antibiotics Sales (2019-2030) & (K Units)

Figure 16. Global β-Lactam Antibiotics Average Price (US$/Unit) & (2019-2030)

Figure 17. β-Lactam Antibiotics Report Years Considered

Figure 18. β-Lactam Antibiotics Sales Share by Manufacturers in 2023

Figure 19. Global β-Lactam Antibiotics Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest β-Lactam Antibiotics Players: Market Share by Revenue in 2023

Figure 21. β-Lactam Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global β-Lactam Antibiotics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America β-Lactam Antibiotics Sales Market Share by Country (2019-2030)

Figure 24. North America β-Lactam Antibiotics Revenue Market Share by Country (2019-2030)

Figure 25. United States β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe β-Lactam Antibiotics Sales Market Share by Country (2019-2030)

Figure 28. Europe β-Lactam Antibiotics Revenue Market Share by Country (2019-2030)

Figure 29. Germany β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific β-Lactam Antibiotics Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific β-Lactam Antibiotics Revenue Market Share by Region (2019-2030)

Figure 36. China β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Southeast Asia β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America β-Lactam Antibiotics Sales Market Share by Country (2019-2030)

Figure 44. Latin America β-Lactam Antibiotics Revenue Market Share by Country (2019-2030)

Figure 45. Mexico β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa β-Lactam Antibiotics Sales Market Share by Country (2019-2030)

Figure 49. Middle East & Africa β-Lactam Antibiotics Revenue Market Share by Country (2019-2030)

Figure 50. Turkey β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE β-Lactam Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of β-Lactam Antibiotics by Type (2019-2030)

Figure 54. Global Revenue Market Share of β-Lactam Antibiotics by Type (2019-2030)

Figure 55. Global β-Lactam Antibiotics Price (US$/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of β-Lactam Antibiotics by Application (2019-2030)

Figure 57. Global Revenue Market Share of β-Lactam Antibiotics by Application (2019-2030)

Figure 58. Global β-Lactam Antibiotics Price (US$/Unit) by Application (2019-2030)

Figure 59. β-Lactam Antibiotics Value Chain

Figure 60. β-Lactam Antibiotics Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Distributors Profiles

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions